CXCR4 and renal cell carcinoma: Being considered to drive RCC progression and metastasis, a high content of CXCR-4+CSCs, estimated by the amount of CXCR-4 expression, correlated with a worse prognosis (strong prognostic power for patients without metastases at the time of diagnosis).